Follicular lymphoma: open trials in Canada

10 open trials have a site in Canada. Registry data; only the trial team decides who can take part.

NCT05365659
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Trial Treatment · Phase 1 · Iksuda Therapeutics Ltd.
Jewish General Hospital, Montreal
Registry updated 2026-11-03
NCT07519772
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Hopital Maisonneuve-Rosemont CIUSSS de l Est de L Ile de Montreal ( Site 0305), Montreal · Princess Margaret Cancer Centre ( Site 0301), Toronto
Registry updated 2026-10-29
NCT06549595
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Trial Treatment · Phase 3 · AstraZeneca
Barrie · Chicoutimi · Halifax · Hamilton · Montreal · Oshawa · Québec · Saint-Jérôme · Toronto · Winnipeg
Registry updated 2026-10-21
NCT06526793
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Trial Treatment · Phase 2 · AstraZeneca
Barrie · Brampton · Ottawa · Toronto
Registry updated 2026-10-14
NCT06806033
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Trial Treatment · Phase 2 · Hoffmann-La Roche
Arthur J.E. Child Comprehensive Cancer Center, Calgary · CancerCare Manitoba (CCMB), Winnipeg
Registry updated 2026-10-09
NCT06091254
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Tom Baker Cancer Center, Calgary · Centre Integre de Sante et de Services Sociaux (CISSS) de la Monteregie-Centre, Greenfield Park · CHU de Quebec-Universite Laval, Québec · Saint John Regional Hospital, Saint John · Ciusss de Lestrie - Centre Hospitalier Universitaire de Sherbrooke (CHUS), Sherbrooke
Registry updated 2026-10-06
NCT05006716
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Trial Treatment · Phase 1/2 · BeOne Medicines
Arthur Je Child Comprehensive Cancer Centre, Calgary · Cross Cancer Institute, Edmonton · Chu de Quebec Universite Laval, Hopital de Lenfant Jesus, Centre Integre de Cancerologie (Cic), Québec · Princess Margaret Cancer Centre, Toronto · British Columbia Cancer Agency the Vancouver Centre, Vancouver
Registry updated 2026-10-05
NCT06542250
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Trial Treatment · Phase 1/2 · AstraZeneca
Calgary · Montreal · Toronto
Registry updated 2026-09-30
NCT06911502
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Trial Treatment · Phase 3 · Celgene
Québec · Sherbrooke · Sherbrooke · Princess Margaret Cancer Centre, Toronto · Victoria
Registry updated 2026-05-20
NCT06830759
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
Research · AbbVie
Cross Cancer Institute /ID# 271504, Edmonton · Health Sciences North /ID# 274738, Greater Sudbury · Kingston General Hospital /ID# 272061, Kingston · The Moncton Hospital /ID# 277230, Moncton · Eastern Health - General Hospital /ID# 272062, St. John's
Registry updated 2026-02-17

All Follicular lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error